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Hypersensitive fingers in female patients with rheumatoid 
arthritis: Reflections on clinical, laboratory and 
functional measures
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Divisions of Rheumatology and Hand Rehabilitation, Ulucanlar, Ankara, Turkey
 
Objective: The hand is the main target in many rheumatic diseases such as 
rheumatoid arthritis (RA) and osteoarthritis (OA), and it is the main tactile sensory 
organ that is uniquely designed for fine motor activities. We aimed to assess 
the quantitative median sensory and motor function of the patients with RA 
and compared it with healthy normal controls (HNCs) and patients with OA to 
investigate the possible relationships. 
Materials-Methods:Disease activity score of 28 joints (DAS28), health 
assessment questionnaire (HAQ), radiographic Larsen score and laboratory test 
results were recorded in RA patients. QST of the median nerve including Semmes- 
Weinstein (S-W) touch pressure thresholds, 2-point discrimination (2-PD) test, and 
pinch strength measurement were performed in all subjects.
Results: Seventy-two female RA patients (mean age 55.9, SD 9.5 years), 43 female 
OA patients (mean age 58.9, SD 4.8 years), and 39 female HNCs (mean age 56.6, 
SD 5.8 years) were recruited to the study (p=0.080 for mean age comparison). 
All patients with RA have used synthetic DMARDs. S-W touch-pressure thresholds 
were better in RA patients than in OA patients and controls (p=0.028). 2-PD results 
were better in controls than in patients with OA (p=0.041). In a multiple linear 
regression analysis of patients with RA, the significant predictors (p<0.05) of the 
S-W touch pressure threshold of median nerve were duration of disease, DAS28, 
HAQ, rheumatoid hand deformities and laboratory parameters including CCP, RF, 
CRP and platelet count.
Conclusion: Future studies are needed to determine the effect of pharmacologic 
and non-pharmacologic strategies on the hypersensitive fingers in RA. In particular, 
the effects of biologic DMARDs of RA or drugs for neuropathic pain on the sensory 
dysfunction in rheumatoid hands should be investigated.
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Objective: The LMAP is a group self-management programme of two modules 
(weekly meetings: 4 x 2.5h) plus review (2h). Module A includes: arthritis 
information, joint protection and fatigue management; and module B: exercise 
(flexibility, strength, walking programme, Tai Chi for Arthritis), foot care, pain 
and stress management. A randomized parallel group trial (n=167) demonstrated 
significant improvements at 12 months in pain, perceived control, self-efficacy 
and self-management in people with early inflammatory, rheumatoid or psoriatic 
arthritis, compared to a standard arthritis education programme (SAEP: 10 hours). 
In this study, we evaluated the LMAP’s long-term effects.
Materials-Methods:At 6.5 years (y), the participants completed the trial postal 
questionnaire including: pain 10cm scale; Multi-dimensional Health Assessment 
Questionnaire (MDHAQ: function, psychological status, perceived control), arthritis 
self-efficacy scales, adherence with self-management. Mean change (SD) scores 
from 0-6.5y were compared between groups using ANCOVA, with baseline scores 
as covariates. Data were analysed as a) completers only and b) missing cases’ data 
imputed (estimation-maximization method, 25 iterations using IBM SPSS v20 
software).
Results: 58% responded, 54 (63%) LMAP and 43 SAEP (53%) participants. There 
were no statistically significant differences in baseline characteristics of responders 
versus non-responders or response rates between groups. Among completers, the 
LMAP group had better use of joint protection (p=0.03), with no other statistically 
significant differences. After multiple imputation, the LMAP group had better 
self-efficacy for self-management (p=0.05), self-reported use of joint protection 
(p=0.001) and exercise (although less than at 12 months; p=0.05). 
Conclusion: The LMAP led to some long-term benefits in improved self-efficacy 
and use of self-management. Higher self-efficacy is associated with better health 
status (Cross et al, 2006, Rheumatology 45(1):92-6) although in this study other 
benefits, particularly improved pain, were not sustained. We recommend evaluating 
the effect of booster sessions. A limitation was the high drop-out rate.
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